Biography

Paul A. LaViolette is the CEO and Co-chairman of Pulse Biosciences, a novel bioelectric medicine company developing multiple clinical applications using pulsed field ablation technology. Mr. LaViolette brings forty-five years of experience in global medical technology, operating leadership and investing. He is also Managing Partner of SV Health Investors LLC, a specialist healthcare fund management company. Previously, Mr. LaViolette held various positions during his fifteen years with Boston Scientific Corporation ("BSC"), including Chief Operating Officer, President, Cardiology, Group President, Endosurgery and President, international. While at BSC, he integrated dozens of acquisitions and led extensive product development, operations, and worldwide commercial organizations. Before BSC, he held marketing and general management positions at C.R. Bard Inc. and various marketing roles at Kendall, Inc. Mr. LaViolette currently serves on the board of directors of Edwards Lifesciences, and he has served as the chairman or director of six public and over 15 private boards of early and growth stage medical companies. Additionally, Mr. LaViolette serves on the board and was the chairman of the Medical Device Manufacturers Association and is Chairman of the Innovation Advisory board of the Massachusetts General Brigham health system. Mr. LaViolette received his bachelor's degree in Psychology from Fairfield University and earned his MBA from Boston College.